The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis.
about
Primary biliary cirrhosisPrimary biliary cirrhosis: From bench to bedsideNetwork meta-analysis of randomized controlled trials: efficacy and safety of UDCA-based therapies in primary biliary cirrhosisPrimary biliary cirrhosis and liver transplantationA dose-up of ursodeoxycholic acid decreases transaminases in hepatitis C patientsOptimal drug regimens for primary biliary cirrhosis: a systematic review and network meta-analysisAutoimmune cholangitisReview article: mechanisms of action and therapeutic applications of ursodeoxycholic acid in chronic liver diseases.Recurrent primary biliary cirrhosis: peritransplant factors and ursodeoxycholic acid treatment post-liver transplant.Ursodeoxycholic acid treatment of vanishing bile duct syndromes.Primary biliary cirrhosis: new perspectives in diagnosis and treatmentPrognostic Factors for Transplant-Free Survival and Validation of Prognostic Models in Chinese Patients with Primary Biliary Cholangitis Receiving Ursodeoxycholic AcidMedical treatment of cholestatic liver diseases: From pathobiology to pharmacological targets.Autoantigens in primary biliary cirrhosisCurrent status of therapy in autoimmune liver diseaseLong-term effects of mid-dose ursodeoxycholic acid in primary biliary cirrhosis: a meta-analysis of randomized controlled trials.Drug therapy of primary biliary diseases: classical and modern strategies.Fatigue in cholestatic liver disease--a perplexing symptomCharacterisation of patients with primary biliary cirrhosis responding to long term ursodeoxycholic acid treatmentSystematic review: ursodeoxycholic acid--adverse effects and drug interactions.Primary biliary cirrhosis associated with systemic sclerosis: diagnostic and clinical challenges.The diagnosis and treatment of primary biliary cirrhosisApproach to a patient with elevated serum alkaline phosphatase.Molecular mechanisms of ursodeoxycholic acid toxicity & side effects: ursodeoxycholic acid freezes regeneration & induces hibernation mode.Combination of ursodeoxycholic acid and glucocorticoids upregulates the AE2 alternate promoter in human liver cellsUrsodeoxycholic acid therapy for primary biliary cirrhosis. A 10-year British single-centre population-based audit of efficacy and survival.Ursodeoxycholic acid for patients with primary biliary cirrhosis: an updated systematic review and meta-analysis of randomized clinical trials using Bayesian approach as sensitivity analyses.Role of plasmapheresis in the treatment of severe pruritus in pregnant patients with primary biliary cirrhosis: case reports.Clinical features and management of primary biliary cirrhosis.Natural history and management of primary biliary cirrhosis.Hepatic inflammation and progressive liver fibrosis in chronic liver disease.Baseline ductopenia and treatment response predict long-term histological progression in primary biliary cirrhosis.Primary Biliary Cholangitis Alters Functional Connections of the Brain's Deep Gray Matter.Ursodeoxycholic acid and superoxide anion.The ursodeoxycholic acid story in primary biliary cirrhosisProlonged follow-up of patients in the U.S. multicenter trial of ursodeoxycholic acid for primary biliary cirrhosis.The effect of ursodeoxycholic acid on the florid duct lesion of primary biliary cirrhosis.Effect of deoxycholic acid and ursodeoxycholic acid on lipid peroxidation in cultured macrophages.Novel strategies and therapeutic options for the management of primary biliary cholangitis.Recent developments in the management of idiopathic cholestatic liver disease
P2860
Q21202919-B88D8943-6B51-456A-AC7B-3F82CC659CBDQ26799419-E8CDB9FA-E12F-42ED-936E-0B15CF2AB005Q26824664-CD5C22C2-B7C3-42C6-8DC0-B09EAC3712A0Q26853145-916414D7-7A93-44FB-8278-0D29AF68E8CAQ27488742-0F988BCD-2D74-4284-8B44-15EDA45D294CQ28087211-8066F8EC-11E0-4C61-9309-D41A22B0F281Q33617951-59E8B35C-124D-46D0-A584-B5CE0EFD921EQ33723536-1ABD2A6F-A824-42C2-8278-E948CE7DFC6BQ33730935-4D1845E6-FF40-4F28-91F6-1D51BFE966EDQ33866782-EFC1BA05-1636-40E5-93AA-5B9957B3A73EQ33869324-C056D104-B78E-46C7-9E2D-95B463016172Q33920325-EC2B8427-9B1E-47FC-AF5A-9BB99E0C6110Q34017604-34D16202-C456-4BDD-9192-8B3862204000Q34111559-57CB5F0A-7B3B-48DB-A29A-3A2F88CEFA12Q34408950-F1281FA2-907F-43B4-A605-6D18108F4ADEQ34550505-C6E8F4F1-B3C9-4E49-92B4-A0A505B7D700Q34687676-5D6CF49E-1AB0-46B5-AE83-443EFA9085C5Q34769039-35E72D9A-C214-48CE-813E-D3BD25E7CF94Q35358467-77CC91B8-CD61-486D-B067-3D66047323AFQ35583064-95437CDD-F335-4D62-A98F-1D18AD6F0372Q35609106-B59B1F70-DC5B-40FA-B329-DFCD3F97690BQ35833175-4DB96F96-E6CD-4A25-8338-C844799D0E50Q35926418-9FF6678D-E567-40FC-AB76-C052D6B2247FQ36197335-3650B68A-8276-4341-8F99-E928C029F20BQ36330872-41897165-886F-41BA-93C8-21CA4F65BB3AQ36612947-E2520123-DAEC-44A5-BD4A-37E207D2D45BQ36801651-9F815F54-9CBF-4805-8C07-FB0A4947BE2DQ37140216-CD00A88A-8D5C-4503-8F61-F0D0576791D6Q37182934-A6DDD448-C5F1-40CC-868C-F0B97165A418Q37355843-34612AF8-15FD-4BD3-8E95-58B209BC4C5EQ37629675-1AECC634-31EE-46DF-86B0-9CB79D835F88Q37760788-06208C45-1325-4B47-BB1B-3ECB81358745Q38651060-E6B7302A-E4F2-4212-9F36-526AF68707D0Q39677430-E3552975-1F66-483A-B7DE-6F46705BD93AQ40974682-93678397-B853-49CF-AB4F-E8371EB659D0Q41871213-4309CD7A-C7EF-46AC-9133-868E5C0689B4Q41980473-05E1D860-C212-45A3-BE58-9788E4903D59Q42254171-6A5CBDFB-65AD-49AB-8778-FFA09B8C4294Q42375647-BF748EA2-F4E1-4379-B16C-3F601BC39CFBQ42406650-751AC94A-74AC-4622-ABDA-268BF14DABAE
P2860
The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh-hant
name
The Canadian Multicenter Doubl ...... in primary biliary cirrhosis.
@en
The Canadian Multicenter Doubl ...... in primary biliary cirrhosis.
@nl
type
label
The Canadian Multicenter Doubl ...... in primary biliary cirrhosis.
@en
The Canadian Multicenter Doubl ...... in primary biliary cirrhosis.
@nl
prefLabel
The Canadian Multicenter Doubl ...... in primary biliary cirrhosis.
@en
The Canadian Multicenter Doubl ...... in primary biliary cirrhosis.
@nl
P2093
P1433
P1476
The Canadian Multicenter Doubl ...... in primary biliary cirrhosis.
@en
P2093
Blendis LM
Cauch-Dudek K
Heathcote EJ
Michieletti P
P304
P356
10.1016/0270-9139(94)90861-3
P407
P577
1994-05-01T00:00:00Z